Renin inhibitors

Details for Australian Patent Application No. 2010232628 (hide)

Owner Merck Canada Inc. Merck Sharp & Dohme Corp.

Inventors McKay, Daniel J.; Arbour, Melissa; Aspiotis, Renee; Chen, Austin; Dolman, Sarah Jennifer; Fournier, Pierre-Andre; Gallant, Michel; Han, Yongxin; Hughes, Greg; Janey, Jacob; Juteau, Helene; Lacombe, Patrick; Laliberte, Sebastien; Lauzon, Sophie; Macdonald, Dwight; Mackay, Bruce; Mellon, Christophe; Molinaro, Carmela; Morley, Krista L.; O'Shea, Paul; Ramtohul, Yeeman K.; Simard, Daniel; Tsui, Chit

Agent Spruson & Ferguson

Pub. Number AU-A-2010232628

PCT Pub. Number WO2010/114978

Priority 61/211,827 03.04.09 US

Filing date 1 April 2010

Wipo publication date 7 October 2010

International Classifications

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Event Publications

6 October 2011 PCT application entered the National Phase

  PCT publication WO2010/114978 Priority application(s): WO2010/114978

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Canada Inc.; Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010232632-Lyophilization cakes of proteasome inhibitors

2010232614-Architectural pattern for persistent web application design